[1] Yu F,Dong B,Dong P,et al. Hypoxia induces the activation of hepatic stellate cells through the PVT1 miR-152 ATG14 signaling pathway. Mol Cell Biochem,2020,465:115-123.
[2] Tao L,Wu L,Zhang W,et al.Peroxisome proliferator-activated receptor γ inhibits hepatic stellate cell activation regulated by miR-942 in chronic hepatitis B liver brosis.Life Sci,2020,253:117572.
[3] 龚航,李良平.FibroScan 分别与GPR、APRI、NFS、FIB -4 联合应用对慢性乙型肝炎合并非酒精性脂肪性肝病进展期肝纤维化的诊断价值比较. 临床肝胆病杂志, 2020,36:541-545.
[4] Hussein RM,Anwar MM,Farghaly HS,et al.Gallic acid and ferulic acid protect the liver from thioacetamide-induced fibrosis in rats via differential expression of miR-21, miR-30 and miR-200 and impact on TGF-β1/Smad3 signaling. Chem Biol Interact,2020,324:109098.
[5] 李俊,郭旭利,黄维甄.miR-375、miR-146a在原发性肝癌患者预后评估中的价值.肝脏,2019,23:268-271.
[6] 血清miRNA-130a与HBV相关慢加急性(亚急性)肝衰竭患者预后的相关性分析,肝脏,2019,24:158-160.
[7] Wei C, Zhao WS, Yang AT,et al.Integrated analysis of microRNA and gene expression profiles reveals a functional regulatory module associated with liver fibrosis.Gene,2017,636:87-95.
[8] Li J,Jin B,Wang T,et al. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma. Cancer Biomark, 2019, 26:501-512.
[9] Fan HX, Feng YJ, Zhao XP,et al.MiR-185-5p suppresses HBV gene expression by targeting ELK1 in hepatoma carcinoma cells. Life Sci,2018,213:9-17.
[10] Yuan Q,Xu T,Chen Y,et al. MiR-185-5p ameliorates endoplasmic reticulum stress and renal fibrosis by downregulation of ATF6. Lab Invest,2020,100:1436-1446.
[11] Chen X,Zhang D,Wang Y,et al. Synergistic antifibrotic effects of miR-451 with miR-185 partly by co-targeting EphB2 on hepatic stellate cells. Cell Death Dis,2020,11:402.
[12] Lin HY, Wang FS, Yang YL,et al.MicroRNA-29a suppresses CD36 to ameliorate high fat diet-induced steatohepatitis and liver fibrosis in mice. Cells,2019,8:1298.
[13] Kong M,Wu J,Fan Z,et al. The histone demethylase Kdm4 suppresses activation of hepatic stellate cell by inducing miR-29 transcription. Biochem Biophys Res Commun,2019, 514:16-23.
[14] Huang YH,Kuo HC,Yang YL,et al.MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation. Int J Med Sci,2019,16:212-220.
[15] Zhang Y,Yao XH,Wu Y,et al. LncRNA NEAT1 regulates pulmonary fibrosis through miR-9-5p and TGF-β signaling pathway. Eur Rev Med Pharmacol Sci,2020,24:8483-8492.
[16] Yang S,Cai H,Hu B,et al.LncRNA SAMMSON negatively regulates miR-9-3p in hepatocellular carcinoma cells and has prognostic values. Biosci Rep,2019; 39:BSR20190615.
[17] Sun J, Zhang H,Li L,et al. MicroRNA-9 limits hepatic fibrosis by suppressing the activation and proliferation of hepatic stellate cells by directly targeting MRP1/ABCC1.Oncol Rep,2017,37:1698-1706.
[18] Yu F, Chen B,Fan X,et al.Epigenetically-regulated microRNA-9-5p suppresses the activation of hepatic stellate cells via TGFBR1 and TGFBR2. Cell Physiol Biochem,2017,43:2242-2252.
[19] Xu Q,Zhou L,Yang G,et al.Overexpression of circ_0001445 decelerates hepatocellular carcinoma progression by regulating miR-942-5p/ALX4 axis. Biotechnol Lett,2020,42:2735-2747.
[20] Tao L,Xue D,Shen D,et al.MicroRNA-942 mediates hepatic stellate cell activation by regulating BAMBI expression in human liver fibrosis. Arch Toxicol,2018,92:2935-2946.
[21] Tao L,Wu L,Zhang W,et al. Peroxisome proliferator-activated receptor γ inhibits hepatic stellate cell activation regulated by miR-942 in chronic hepatitis B liver fibrosis. Life Sci,2020,253:117572.
[22] Zhu J,Zhang Z,Zhang Y,et al. MicroRNA-212 activates hepatic stellate cells and promotes liver fibrosis via targeting SMAD7. Biochem Biophys Res Commun,2018,496:176-183.
[23] Ma T, Cai X, Wang Z,et al. miR-200c accelerates hepatic stellate cell-induced liver fibrosis via targeting the FOG2/PI3K pathway. Biomed Res Int, 2017:2670658.
[24] Wang Y,Zeng Z,Guan L,et al.GRHL2 induces liver fibrosis and intestinal mucosal barrier dysfunction in non-alcoholic fatty liver disease via microRNA-200 and the MAPK pathway.J Cell Mol Med,2020,24:6107-6119.
[25] Chen C, Li X, Wang L. Thymosinβ4 alleviates cholestatic liver fibrosis in mice through downregulating PDGF/PDGFR and TGFβ/Smad pathways.Dig Liver Dis,2020,52:324-330. |
